Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
CC transcript
|
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| Barbo William D (Corporate Executive VP & CCO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 5,763 shares
@ $217.24, valued at
$1.3M
Exercised 5,511 options to buy
@ $144.67, valued at
$797.3k
|
|
| 08/14/2023 |
4
| Knell Michael Gunnar (CSVP&Chief Accounting Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 1,471 shares
@ $216.54, valued at
$318.5k
Exercised 1,471 options to buy
@ $144.67, valued at
$212.8k
|
|
| 08/14/2023 |
4
| FOSTER JAMES C (Chairman, President and CEO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Gifted 2,500 shares
@ $0 |
|
| 08/14/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 700 shares
@ $216.52, valued at
$151.6k
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended July 1, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 10.2% stake in CHARLES RIVER LABORATORIES INTERNATIONAL INC |
| 07/05/2023 |
4
| MACKAY MARTIN (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 95 shares
@ $0 |
|
| 06/02/2023 |
4
| MACKAY MARTIN (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 338 shares
@ $0 |
|
| 05/31/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 2,189 shares
@ $0
Paid exercise price by delivering 184 shares
@ $194.12, valued at
$35.7k
Paid exercise price by delivering 125 shares
@ $194.12, valued at
$24.3k
Paid exercise price by delivering 223 shares
@ $194.12, valued at
$43.3k
Granted 5,252 options to buy
@ $194.12, valued at
$1M
|
|
| 05/31/2023 |
4
| Knell Michael Gunnar (CSVP&Chief Accounting Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 670 shares
@ $0
Paid exercise price by delivering 36 shares
@ $194.12, valued at
$7k
Paid exercise price by delivering 24 shares
@ $194.12, valued at
$4.7k
Paid exercise price by delivering 36 shares
@ $194.12, valued at
$7k
Granted 1,607 options to buy
@ $194.12, valued at
$312k
|
|
| 05/31/2023 |
4
| Pease Flavia (Corporate Executive VP & CFO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 2,215 shares
@ $0
Paid exercise price by delivering 137 shares
@ $194.12, valued at
$26.6k
Granted 5,314 options to buy
@ $194.12, valued at
$1M
|
|
| 05/31/2023 |
4
| FOSTER JAMES C (Chairman, President and CEO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Paid exercise price by delivering 1,274 shares
@ $194.12, valued at
$247.3k
Granted 28,176 options to buy
@ $194.12, valued at
$5.5M
|
|
| 05/31/2023 |
4
| Barbo William D (Corporate Executive VP & CCO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 1,958 shares
@ $0
Paid exercise price by delivering 166 shares
@ $194.12, valued at
$32.2k
Paid exercise price by delivering 112 shares
@ $194.12, valued at
$21.7k
Paid exercise price by delivering 202 shares
@ $194.12, valued at
$39.2k
Granted 4,696 options to buy
@ $194.12, valued at
$911.6k
|
|
| 05/31/2023 |
4
| Girshick Birgit (Corporate Executive VP & COO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 3,812 shares
@ $0
Paid exercise price by delivering 242 shares
@ $194.12, valued at
$47k
Paid exercise price by delivering 132 shares
@ $194.12, valued at
$25.6k
Paid exercise price by delivering 216 shares
@ $194.12, valued at
$41.9k
Granted 9,145 options to buy
@ $194.12, valued at
$1.8M
|
|
| 05/31/2023 |
4
| Parisotto Shannon M (CEVP, Disc & Safety Assessment) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 1,700 shares
@ $0
Paid exercise price by delivering 105 shares
@ $194.12, valued at
$20.4k
Paid exercise price by delivering 71 shares
@ $194.12, valued at
$13.8k
Paid exercise price by delivering 110 shares
@ $194.12, valued at
$21.4k
Granted 4,078 options to buy
@ $194.12, valued at
$791.6k
|
|
| 05/31/2023 |
4
| Creamer Victoria L (EVP & Chief People Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 2,009 shares
@ $0
Paid exercise price by delivering 170 shares
@ $194.12, valued at
$33k
Paid exercise price by delivering 115 shares
@ $194.12, valued at
$22.3k
Paid exercise price by delivering 190 shares
@ $194.12, valued at
$36.9k
Granted 4,820 options to buy
@ $194.12, valued at
$935.7k
|
|
| 05/25/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/17/2023 |
4
| WALLMAN RICHARD F (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 664 shares
@ $0
Granted 1,669 options to buy
@ $192.36, valued at
$321k
|
|
| 05/17/2023 |
4
| FOSTER JAMES C (Chairman, President and CEO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Gifted 3,811 shares
@ $0
Gifted 3,812 shares
@ $0 |
|
| 05/17/2023 |
4
| Llado George Sr. (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 664 shares
@ $0
Granted 1,669 options to buy
@ $192.36, valued at
$321k
|
|
| 05/17/2023 |
4
| Kochevar Deborah Turner (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 664 shares
@ $0
Granted 1,669 options to buy
@ $192.36, valued at
$321k
|
|
| 05/17/2023 |
4
| BERTOLINI ROBERT J (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 664 shares
@ $0
Granted 468 shares
@ $0
Granted 1,669 options to buy
@ $192.36, valued at
$321k
|
|
| 05/17/2023 |
4
| Andrews Nancy C (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 664 shares
@ $0
Granted 1,669 options to buy
@ $192.36, valued at
$321k
|
|
| 05/15/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 950 shares
@ $193.02, valued at
$183.4k
Sold 9 shares
@ $194.07, valued at
$1.7k
|
|
| 05/15/2023 |
4
| MASSARO GEORGE (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 288 shares
@ $193.43, valued at
$55.7k
|
|
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended April 1, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
|
|
|